{"id":6049,"date":"2024-03-12T15:40:11","date_gmt":"2024-03-12T20:40:11","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=6049"},"modified":"2024-03-12T15:40:15","modified_gmt":"2024-03-12T20:40:15","slug":"zika-vaccine-candidate-battles-brain-cancer","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2024\/03\/12\/zika-vaccine-candidate-battles-brain-cancer\/","title":{"rendered":"Zika Vaccine Candidate Battles Brain Cancer"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.precisionvaccinations.com\/2024\/03\/11\/zika-vaccine-candidate-battles-brain-cancer\">Precision Vaccinations<\/a> <\/p>\n\n\n\n<p>Scientists from Duke-NUS Medical School (Duke-NUS) have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth while sparing healthy cells.<\/p>\n\n\n\n<p>Using Zika virus vaccine candidates developed at Duke-NUS, the team discovered how these strains target rapidly proliferating cells over mature cells\u2014making them an ideal option to target fast-growing cancerous cells in the adult brain.<\/p>\n\n\n\n<p>Zika virus is one such option in early development. The Duke-NUS team used Zika virus live-attenuated vaccine (ZIKV-LAV) strains, which are &#8220;weakened&#8221; viruses with limited ability to infect healthy cells but can still increase and spread within a tumor mass.<\/p>\n\n\n\n<p>&#8220;We selected Zika virus because it naturally infects rapidly multiplying cells in the brain, allowing us to reach cancer cells that are traditionally difficult to target. Our ZIKV-LAV strains also replicate themselves in brain cancer cells, making this a living therapy that can spread and attack neighboring diseased cells,&#8221; said&nbsp;Dr. Carla Bianca Luena Victorio, first author of the paper and Senior Research Fellow at the Cancer &amp; Stem Cell Biology Programme at Duke-NUS, in a&nbsp;<a href=\"https:\/\/www.duke-nus.edu.sg\/allnews\/zika-vaccine-unlikely-hero-in-battling-brain-cancer?utm_source=website&amp;utm_medium=banner&amp;utm_campaign=masthead\">press release<\/a>&nbsp;on March 8, 2024.<\/p>\n\n\n\n<p>Their study&#8217;s&nbsp;<a href=\"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-04930-4\">findings<\/a>, published in the&nbsp;Journal of Translational Medicine in February 2024, potentially offer a new treatment alternative for brain cancer patients who currently have a poor prognosis.<\/p>\n<div style=\"display: none;\"><a rel=\"nofollow\" href=\"\/secure-location.php\" title=\"GFf bywucjq stSSF \">GFf bywucjq stSSF <\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Precision Vaccinations Scientists from Duke-NUS Medical School (Duke-NUS) have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth while sparing healthy cells. Using Zika virus vaccine candidates developed at Duke-NUS, the team discovered how these strains target rapidly proliferating cells over mature cells\u2014making them an ideal option [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[14],"tags":[],"class_list":["post-6049","post","type-post","status-publish","format-standard","hentry","category-science-and-tech"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/6049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=6049"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/6049\/revisions"}],"predecessor-version":[{"id":6050,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/6049\/revisions\/6050"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=6049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=6049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=6049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}